Reposted from BetaKit | Toronto-based MolecuLight, which develops fluorescence-guided imaging for visualizing bacteria of chronic wounds, has received a $7.5 million USD loan from Oxford Finance. Oxford Finance provides senior debt to life sciences and healthcare services companies, and has originated over $5 billion in loans, with lines of credit ranging from $5 million to [...]Continue reading

Globalive Media’s “Beyond Innovation”, which aired on Bloomberg Television around the world. MolecuLight uses new imaging technology to help clinicians take the guesswork out of their treatment plans. Dr. Ralph DaCosta, Founder and Chief Scientific Officer tells Anthony Lacavera how light can automatically visualize bacteria at every stage of wound care